Literature DB >> 34774595

Gentiana straminea Maxim. polysaccharide decolored via high-throughput graphene-based column and its anti-inflammatory activity.

Shuo Shi1, Guocheng Wang1, Jie Liu1, Sunan Liu1, Qiuyu Xu1, Xi Lan1, Jianxing Feng1, Jing Sun2, Wentao Zhang1, Jianlong Wang3.   

Abstract

Gentiana straminea Maxim. exhibits various biological activities. However, the purification and functions of polysaccharides in Gentiana straminea Maxim. have never been reported. Herein, by proposing a flexible 3D graphene-based decoloration column (3DD column), Gentiana straminea Maxim. polysaccharide (GMP) was high-throughput obtained and its anti-inflammatory activity was investigated. Benefiting from the large macroporous network of 3D NH2-graphene oxide hydrogel with selective adsorption towards pigments, the 3DD column exhibits high decoloration ratio (96.41%). In addition, the 3DD column provides superior practical functionality as compared to the traditional approaches, which are time-consuming and need toxic solvents, and exhibiting widespread-application for the purification of polysaccharide from other common plant species. More importantly, the decolored GMP as a natural product has promising anti-inflammatory activity on RAW264.7 cells without negative impact on cell viability. Overall, this work reveals a new functional polysaccharides and provides a flexible approach for polysaccharide decoloration, exhibiting a promising prospect for natural polysaccharides in practical application of pharmaceutical.
Copyright © 2021. Published by Elsevier B.V.

Entities:  

Keywords:  3D graphene-based decoloration column; Anti-inflammatory activity; Gentiana straminea Maxim; Polysaccharides

Mesh:

Substances:

Year:  2021        PMID: 34774595     DOI: 10.1016/j.ijbiomac.2021.11.010

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  1 in total

1.  Effective Parts of Gentiana straminea Maxim Attenuates Hypoxia-Induced Oxidative Stress and Apoptosis.

Authors:  Dan Song; Jingyu Zhang; Jie Li; Xiumei Kong; Yi Jiang; Jiaojiao Xu; Xiaoying Zhang; Qin Zhao
Journal:  Dose Response       Date:  2022-05-17       Impact factor: 2.623

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.